Übersichtsarbeit
Emerging therapies and future directions in chronic lymphocytic leukaemia - chemotherapy
Hematology and Cell Therapy · 2000
DOI: 10.1007/s00282-000-0041-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematology and Cell Therapy, 2000. Verfasst von B D Cheson. Beteiligte Einrichtung: Clinical Investigations Branch, National Cancer Institute, Bethesda, MD 20892-7436, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Angiogenesis InhibitorsAntineoplastic Combined Chemotherapy ProtocolsDrug DesignForecastingGrowth SubstancesHumansLeukemia, Lymphocytic, Chronic, B-CellOrganoplatinum CompoundsOxaliplatin
Substanzen
Angiogenesis InhibitorsGrowth SubstancesOrganoplatinum CompoundsOxaliplatin
Autor:innen und Institutionen
- Clinical Investigations Branch, National Cancer Institute, Bethesda, MD 20892-7436, USA.
Zitieren
APA
Cheson, B. D. (2000). Emerging therapies and future directions in chronic lymphocytic leukaemia - chemotherapy. Hematology and Cell Therapy. https://doi.org/10.1007/s00282-000-0041-0
Vancouver
Cheson BD. Emerging therapies and future directions in chronic lymphocytic leukaemia - chemotherapy. Hematology and Cell Therapy. 2000. doi:10.1007/s00282-000-0041-0
BibTeX
@article{Cheson2000,
author = {Cheson, B D},
title = {Emerging therapies and future directions in chronic lymphocytic leukaemia - chemotherapy},
journal = {Hematology and Cell Therapy},
year = {2000},
doi = {10.1007/s00282-000-0041-0}
}
EUVIMED